Stockreport

BioAtla: A Buried ADC Concern Gets Some New Life In 2024 [Seeking Alpha]

BioAtla, Inc.  (BCAB) 
PDF Their approach is an attempt to harness the Warburg effect to conditionally activate immunological molecules. BioAtla has promising pipeline candidates, including mec [Read more]